A compounded diagnosis: maxillary osteochemonecrosis in the setting of low dose radiotherapy.
Magliocca
Kelly R
KR
Department of Oral and Maxillofacial Surgery and Oral Diagnostic Sciences, University of Florida School of Dentistry, Gainesville, FL 32608, USA. cottrk@hotmail.com
Stavropoulos
Mary F
MF
Bhattacharyya
Indraneel
I
Cohen
Donald M
DM
D000368:Aged; D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008439:Maxillary Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis*; D010025:Osteoradionecrosis / Q000175:diagnosis; D010039:Otorhinolaryngologic Neoplasms / Q000532:radiotherapy; D011879:Radiotherapy Dosage
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate